Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011

Lauren E. Wilson; Craig Evan Pollack; Melissa A. Greiner; Michaela A. Dinan

doi:10.1007/s10549-018-4746-6

Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4746-6 ◽

2018 ◽

Vol 170 (2) ◽

pp. 361-371 ◽

Cited By ~ 5

Author(s):

Lauren E. Wilson ◽

Craig Evan Pollack ◽

Melissa A. Greiner ◽

Michaela A. Dinan

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Recurrence Score ◽

Early Stage Breast Cancer ◽

Genomic Testing ◽

Medicare Beneficiaries ◽

Physician Characteristics

Download Full-text

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009

JAMA Oncology ◽

10.1001/jamaoncol.2015.2722 ◽

2015 ◽

Vol 1 (8) ◽

pp. 1098 ◽

Cited By ~ 40

Author(s):

Michaela A. Dinan ◽

Xiaojuan Mi ◽

Shelby D. Reed ◽

Gary H. Lyman ◽

Lesley H. Curtis

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Recurrence Score ◽

Early Stage Breast Cancer ◽

Medicare Beneficiaries

Download Full-text

Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens

Annals of Surgical Oncology ◽

10.1245/s10434-021-10457-5 ◽

2021 ◽

Author(s):

Javier I. J. Orozco ◽

Shu-Ching Chang ◽

Chikako Matsuba ◽

Miquel Ensenyat-Mendez ◽

Gary L. Grunkemeier ◽

...

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Core Needle Biopsy ◽

Needle Biopsy ◽

Early Stage ◽

Recurrence Score ◽

Early Stage Breast Cancer ◽

Surgical Specimen ◽

Core Needle

Download Full-text

P253 Economic impact of 21-gene recurrence score testing on early stage breast cancer in Ireland

The Breast ◽

10.1016/s0960-9776(15)70285-7 ◽

2015 ◽

Vol 24 ◽

pp. S113 ◽

Cited By ~ 2

Author(s):

L. Smyth ◽

G. Watson ◽

C.M. Kelly ◽

M. Keane ◽

M.J. Kennedy ◽

...

Keyword(s):

Breast Cancer ◽

Economic Impact ◽

Early Stage ◽

Recurrence Score ◽

Early Stage Breast Cancer

Download Full-text

Abstract PS15-18: Clinical utility of genomic testing for early stage breast cancer patients treated with APBI brachytherapy

10.1158/1538-7445.sabcs20-ps15-18 ◽

2021 ◽

Author(s):

Roberto Diaz ◽

Matthew N Mills ◽

Ronica H Nanda ◽

Lisa L Stout ◽

Scott Dube ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Clinical Utility ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Genomic Testing ◽

Breast Cancer Patients

Download Full-text

The Effect of Physician Characteristics and Their Practice Environment on Surgical Referral Patterns for Early-Stage Breast Cancer in Iowa

American Journal of Medical Quality ◽

10.1177/106286060401900606 ◽

2004 ◽

Vol 19 (6) ◽

pp. 266-273 ◽

Cited By ~ 1

Author(s):

Jessica A. Davila ◽

John M. Brooks ◽

Jane F. Pendergast ◽

Elizabeth A. Chrischilles

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Practice Environment ◽

Referral Patterns ◽

Physician Characteristics ◽

Surgical Referral

Download Full-text

Abstract P5-08-06: Comparison of risk prediction with the 21-gene recurrence score (oncotype DX) and the 70-gene signature (MammaPrint) in patients with estrogen receptor-positive early stage breast cancer

10.1158/1538-7445.sabcs15-p5-08-06 ◽

2016 ◽

Cited By ~ 1

Author(s):

H Jiang ◽

N Denduluri ◽

M Majure ◽

A Favret ◽

HS Rugo

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Risk Prediction ◽

Early Stage ◽

Recurrence Score ◽

Gene Signature ◽

Oncotype Dx ◽

Early Stage Breast Cancer ◽

Estrogen Receptor Positive

Download Full-text

Comparison of treatment of early-stage breast cancer among Nurses’ Health Study participants and other Medicare beneficiaries

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-05098-4 ◽

2019 ◽

Vol 174 (3) ◽

pp. 759-767 ◽

Cited By ~ 2

Author(s):

Andrea M. Austin ◽

Nirav S. Kapadia ◽

Gabriel A. Brooks ◽

Tracy L. Onega ◽

A. Heather Eliassen ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Health Study ◽

Medicare Beneficiaries ◽

Study Participants

Download Full-text

Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer

Genetics in Medicine ◽

10.1038/gim.2012.119 ◽

2012 ◽

Vol 15 (3) ◽

pp. 203-211 ◽

Cited By ~ 32

Author(s):

Shelby D. Reed ◽

Michaela A. Dinan ◽

Kevin A. Schulman ◽

Gary H. Lyman

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Cost Effectiveness ◽

Early Stage ◽

Recurrence Score ◽

Early Stage Breast Cancer

Download Full-text

Using the 21-gene recurrence score and the recently developed Recurrence Score-Clinical-Pathologic to assess recurrence risk in patients with node-negative, ER-positive early-stage breast cancer receiving aromatase inhibitor treatment alone.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.592 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 592-592

Author(s):

M. Crager ◽

G. Tang ◽

S. Shak

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Early Stage ◽

Recurrence Score ◽

Recurrence Risk ◽

Early Stage Breast Cancer ◽

Node Negative ◽

Aromatase Inhibitor Treatment ◽

Er Positive ◽

Inhibitor Treatment

Download Full-text

Overall survival in female Medicare beneficiaries with early stage breast cancer receiving bisphosphonates or denosumab.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.530 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 530-530 ◽

Cited By ~ 1

Author(s):

Raul A Herrera Pena ◽

Xiudong Lei ◽

Mariana Chavez-MacGregor ◽

Hui Zhao ◽

Sharon Hermes Giordano ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Medicare Beneficiaries

Download Full-text